This article relies excessively on references to primary sources. Please improve this article by adding secondary or tertiary sources. Find sources: "Ligand Pharmaceuticals" – news · newspapers · books · scholar · JSTOR(October 2022) (Learn how and when to remove this message)
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company located in San Diego, California.[4] Founded in 1987 as Progenix Inc., the company went public in 1992. Initially focused on developing its own drugs, a period of turbulence in the early 2000s culminated in its CEO being ejected by the shareholders and provoked a change in focus to the acquisition of existing drugs and forming partnerships to develop them further.[citation needed]
The company has been the subject of multiple regulatory investigations,[5] negative shorts-seller reports[6] and class action lawsuits amid allegations of securities fraud.[7][8][9][10]
In 2018 its CEO was listed among the top five highest paid CEOs in San Diego.[11]
LigandPharmaceuticals Incorporated is a biopharmaceutical company located in San Diego, California. Founded in 1987 as Progenix Inc., the company went...
who are aiming to "shak[e] up companies’ slothful boards." After LigandPharmaceuticals hired John Higgins as its new CEO in January 2007, Third Point Management...
LigandPharmaceuticals and TAP Pharmaceuticals in 2001. Other quinoline SARMs, like LGD-2941 and LGD-3303, were also subsequently developed by Ligand...
PPARδ receptor agonist that was invented in a collaboration between LigandPharmaceuticals and GlaxoSmithKline in the 1990s. It entered into clinical development...
collaboration between GlaxoSmithKline and LigandPharmaceuticals and is transferred to Novartis Pharmaceuticals. Eltrombopag was initially approved by the...
University of Tennessee that created an arylpropionamide SARM and LigandPharmaceuticals that made a SARM with a quinolone core structure. The name was adopted...
First-in-Class Medication for the Treatment of Molluscum Contagiosum". LigandPharmaceuticals. 5 January 2024. Archived from the original on 8 January 2024. Retrieved...
First-in-Class Medication for the Treatment of Molluscum Contagiosum". LigandPharmaceuticals. 5 January 2024. Archived from the original on 8 January 2024. Retrieved...
antineoplastic (anti-cancer) agent developed by LigandPharmaceuticals. It is a first generation retinoid. Ligand gained Food and Drug Administration (FDA)...
acquired by LigandPharmaceuticals. Rights to Aplindore were given to Ligand around time of merger. As of 2008, Phase II was completed and Ligand. Upon reviewing...
atrophy, and the result of an exclusive research collaboration with LigandPharmaceuticals (LGND). It also appears to have had a statistically significant...
function. If substances have medicinal properties, they are considered pharmaceuticals. The field encompasses drug composition and properties, functions,...
was listed on AIM until its acquisition by Ligand Holdings (UK) Ltd, a subsidiary of LigandPharmaceuticals, Inc. (NASDAQ:LGND) on 10 October 2018. Vernalis...
therapeutics have also been developed. The phrase "drug design" is similar to ligand design (i.e., design of a molecule that will bind tightly to its target)...
poor stability." In June 2020, LigandPharmaceuticals revealed that Gilead has been managing those issues by mixing Ligand's proprietary excipient Captisol...
2018, Vernalis Research became a subsidiary of Ligand Holdings UK Ltd, wholly owned by LigandPharmaceuticals, Inc. On 2 December 2020, HitGen (Chengdu, China)...
Ethylenediamine (abbreviated as en when a ligand) is the organic compound with the formula C2H4(NH2)2. This colorless liquid with an ammonia-like odor...